We are a team of award-winning scientists with a mission to empower individuals to make better-informed decisions about their skin health.
Sequential Skin is the result of the founders’ passion for molecular genetics.
During their joint studies, they realized that there was a practical application to their research that they had never realized could be so impactful. The microbiome that exists within the body is also present along the lining of the outer layer of the skin. The founders discovered that when the bacteria in the skin microbiome are not balanced enough, it can lead to skin problems.
This pushed them to uncover what it would take in order for the skin microbiome to be at its healthiest and how it would completely revolutionize the way in which people search for their skincare products. Instead of relying on their own diagnosis of their skin, consumers could have the option to truly unearth the secrets that lie on the surface of their skin.
Based on these truths that were hidden in plain sight, they would be able to understand what their skin needs as dictated by their own skin.
Sequential Skin was born from scientific research and discovery for the purpose of bettering people’s chances of having healthy skin without going through the trial and error process of discovering what their skin’s needs truly are.
The diversity of the skin microbiome matters immensely. So does diversity in society. At Sequential Skin, we are a group of passionate individuals who come from all over the world and celebrate multiculturalism recognizing the importance of standing united.
Dr. Oliver Worsley
CEO & CO-FOUNDER
Dr. Albert Dashi
CHIEF SCIENCE OFFICER & CO-FOUNDER
Petronille Houdart, PharmD
Trusted by dermatologists
Sequential Skin’s test is to pioneer a next-generation skin microbiome test to be able to help with identification, analysis and early-stratification of the skin microbiome. It’s known the skin microbiome is dysbalanced in certain people, and so understanding the progression of skin microbiome colonization between healthy skin and skin traits is paramount.
Further research and studies in the skin microbiome field is much needed and the Sequential Skin team is pivotal in this respect. The team is interrogating the skin microbiome for its potential to find new ways to improve the health of the skin.
DR NATALYA FOX, DERMATOLOGIST,
NHS (EPSOM AND ST HELIER UNIVERSITY HOSPITALS)
MBCHB UNIVERSITY OF EDINBURGH 2014, FULL MRCP (UK)
DR LUSHEN PILLAY, HEAD OF DERMATOLOGY
MD WITS UNIVERSITY, SOUTH AFRICA
Board of Advisors
Our advisors are world leaders in the skin microbiome and have extensive experience in bringing forward solutions for skin concerns
Dr Lushen Pillay
Dr Natalya Fox
Prof. Elena Lurie-Luke
Prof. Niranjan Nagarajan
Prof. Tom Dawson
Please find listed a selection of relevant peer-reviewed publications from our advisors.
Wu G, TL Dawson, et al. (2015) Genus-Wide Comparative Genomics of Malassezia Delineates Its Phylogeny, Physiology, and Niche Adaptation on Human Skin. PLOS Genetics 11(11): e1005614.
Chng, K., Nagarajan, N., et al. (2016) Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol 1, 16106.
Tay, A.S., Nagarajan, N., et al (2018). 1039 Skin microbiome profiles of atopic dermatitis patients segregate into two community composition types that are stable before and after therapy. Journal of Investigative Dermatology. 138. S176. 10.1016/j.jid.2018.03.1051.
Ramasamy S., Barnard, E., Dawson, TL, and Huiying Li. (2019). Role of the skin microbiota in acne pathophysiology. British Journal of Dermatology, https://doi.org/10.1111/bjd.18230.
Dawson, TL. (2019) Malassezia: The Forbidden Kingdom Opens. Cell Host Microbe https://doi.org/10.1016/j.chom.2019.02.010
Tay, A.S., Nagarajan, N., et al (2020). Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. The Journal of allergy and clinical immunology. 10.1016/j.jaci.2020.09.031.
Dawson, TL. (2021) Malassezia: A Skin Commensal Yeast Impacting Both Health and Disease. Front. Cell. Infect. Microbiol., doi.org/10.3389/fcimb.2021.659219